Jennifer Rymer, MD

Interventional cardiologist
Duke, North Carolina, United States

Disclosure(s): Abiomed Inc: Contracted Research (Ongoing); Chiesi Inc: Advisor (Ongoing), Contracted Research (Ongoing); idorsia pharmaceuticals: Clinical Trial Investigator (Ongoing); Novo Nordisk: Clinical Trial Investigator (Ongoing), Contracted Research (Ongoing)

Presentation(s):

• SESSION II: DIVERSITY EQUITY & INCLUSION (DEI) IN CV DEVICE RESEARCH

  Saturday, March 9, 2024
  2:05 PM – 3:05 PM ET

• Discussion Panel

  Saturday, March 9, 2024
  2:45 PM – 3:05 PM ET

• Diversity, Equity & Inclusion in CV Device Evaluation

  Saturday, March 9, 2024
  4:45 PM – 5:55 PM ET

• HIGH-RISK AND COMPLEX CASE REVIEW FOR THE EARLY PRACTITIONER [Non-CME] – Sponsored by Chiesi USA, Inc.

  Sunday, March 10, 2024
  6:30 AM – 7:55 AM ET

• Panel Discussion

  Sunday, March 10, 2024
  6:58 AM – 7:08 AM ET

• Panel Discussion

  Sunday, March 10, 2024
  7:16 AM – 7:26 AM ET

• Panel Discussion

  Sunday, March 10, 2024
  7:34 AM – 7:44 AM ET

• Increasing Data on Bifurcation Two-Stent Strategies: To Crush or Not to Crush

  Sunday, March 10, 2024
  9:33 AM – 9:41 AM ET

• Panel Discussion | Who Should Get MCS for High-Risk PCI and with Which Device?

  Sunday, March 10, 2024
  9:41 AM – 9:56 AM ET

• Cangrelor in Contemporary Practice: New Data from the CAMEO Registry

  Sunday, March 10, 2024
  7:50 PM – 8:00 PM ET

• Panel Discussion

  Sunday, March 10, 2024
  8:10 PM – 8:25 PM ET

• Q&A with the Panel

  Sunday, March 10, 2024
  8:45 PM – 9:00 PM ET

• Intravascular Imaging in Endovascular Interventions

  Monday, March 11, 2024
  4:02 PM – 4:10 PM ET

• Panel Discussion | Recap of Session

  Monday, March 11, 2024
  5:06 PM – 5:30 PM ET